| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 174.795 | 210.823 | 236.722 | 280.436 | 332.434 | 321.479 | 251.228 | 245.449 | 239.458 | 230.078 |
| Total Income - EUR | 175.122 | 210.830 | 237.023 | 280.567 | 335.374 | 330.028 | 252.955 | 245.580 | 249.653 | 232.248 |
| Total Expenses - EUR | 171.362 | 191.342 | 210.700 | 247.265 | 310.326 | 294.556 | 261.097 | 246.410 | 269.173 | 240.523 |
| Gross Profit/Loss - EUR | 3.761 | 19.489 | 26.323 | 33.303 | 25.048 | 35.473 | -8.142 | -830 | -19.520 | -8.276 |
| Net Profit/Loss - EUR | 3.159 | 16.370 | 23.082 | 30.494 | 21.715 | 32.545 | -10.672 | -3.286 | -22.016 | -15.241 |
| Employees | 5 | 6 | 5 | 5 | 6 | 6 | 5 | 4 | 4 | 4 |
Check the financial reports for the company - Vetpharm Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 7.746 | 23.463 | 47.697 | 72.038 | 97.206 | 115.603 | 104.047 | 87.014 | 83.164 | 52.667 |
| Current Assets | 12.706 | 33.461 | 19.306 | 26.835 | 39.848 | 38.305 | 38.136 | 29.348 | 24.470 | 28.787 |
| Inventories | 4.441 | 5.984 | 9.813 | 16.686 | 25.982 | 17.836 | 16.451 | 12.885 | 9.561 | 16.212 |
| Receivables | 6.727 | 10.976 | 2.536 | 2.551 | 8.549 | 18.496 | 19.600 | 13.984 | 8.458 | 4.748 |
| Cash | 1.538 | 16.502 | 6.958 | 7.598 | 5.318 | 1.973 | 2.084 | 2.478 | 6.451 | 7.826 |
| Shareholders Funds | 11.345 | 27.600 | 37.573 | 67.378 | 69.142 | 100.376 | 87.478 | 84.464 | 62.192 | 46.603 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 9.107 | 29.324 | 29.430 | 31.496 | 67.913 | 53.533 | 54.704 | 31.898 | 45.442 | 34.850 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7500 - 7500" | |||||||||
| CAEN Financial Year |
7500
|
|||||||||
Comments - Vetpharm Srl